Health
Pfizer, BioNTech Shares Ripe for a Bumpy Ride Ahead of Key Panel – BloombergQuint
Pfizer, BioNTech Shares Ripe for a Bumpy Ride Ahead of Key Panel
(Bloomberg) — Its been a wild ride for Pfizer Inc. shares as the S&P 500 heavyweight got caught up in the vaccine-stock euphoria. A key panel next week could mean even more volatility.
A Food and Drug Administration advisory committee meeting scheduled for Dec. 10 is believed to be a means for the agency to assure the public about Covid-19 vaccine safety, and a U.S. emergency use authorization could follow within days.
Pfizer shares have gained about 20% since late October even after a dip on Thursday,…
-
Noosa News22 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News22 hours agoWoman loses arm in lion attack at Darling Downs Zoo in Queensland
-
Noosa News21 hours agoMissing man, Maroochydore – Queensland Police News
-
General11 hours agoAustralian picture books aim to give neurodivergent kids a better sense of self